ADVFN - Advanced Financial Network.
HOME» NYSE » M » MDT Stock Price » MDT Stock News

Medtronic Share News

 Medtronic, Inc. Stock Price
MDT Stock Price
 Medtronic, Inc. Stock Chart
MDT Stock Chart
 Medtronic, Inc. Stock News
MDT Stock News
 Medtronic, Inc. Company Information
MDT Company Information
 Medtronic, Inc. Stock Trades
MDT Stock Trades

St Jude Medical: Early Results From Riata Lead Evaluation Consistent With Other Studies

By Melodie Warner St. Jude Medical Inc. (STJ) said early results from the Riata lead evaluation study indicate externalized conductors occur less frequently in thinner leads and the rates were consistent with other published studies. The medical-device company voluntarily stopped selling its Riata and Riata ST silicone defibrillation leads in December 2010 following reports of wires wearing through their silicone covering. The latest study's Phase 1 results found that externalized conductors--or the appearance on x-ray or fluoroscopy of conductors outside of the lead body--occurred in 9.3% of the smaller-diameter Riata ST 7F leads in the study, and in 24% of the larger-diameter Riata 8F leads. The study enrolled 724 patients at 20 sites in the U.S. and Canada. An additional 51 patients were enrolled at three sites in Japan and those results are awaiting final adjudication and will be reported at a later date. "The rates of externalized conductors in this study are consistent with other published studies involving fluoroscopic screening of patients with Riata leads," said Mark Carlson, chief medical officer and senior vice president of clinical affairs for the St. Jude Medical Cardiac Rhythm Management Division. "This study also reinforces that externalized conductors are more prevalent in larger-diameter Riata leads." The study will continue to evaluate the performance of Riata leads over the next two years to determine how they function over time. The company said in other clinical studies, the majority of leads with an externalized conductor continued to function normally. St. Jude Medical said its independent leads medical advisory board has reviewed the results and recommends no changes to existing patient management recommendations. The company said it will now focus on collecting longer-term data in the second phase of this study in order to provide physicians "timely and relevant clinical data to best support their patient management decisions." In April, St. Jude said it was seeking a retraction of a study published in the February edition of the Heart Rhythm Journal medical periodical that found heart-defibrillator wires made by the company were responsible for at least 20 deaths, citing inaccurate facts and biased analysis. The study also purported the deaths allegedly caused by Riata malfunctions were about nine times greater than a competing lead called the Quattro Secure made by Medtronic Inc. (MDT). Write to Melodie Warner at melodie.warner@dowjones.com

Stock News for Medtronic (MDT)
DateTimeHeadline
05/25/201616:33:12Specialized Disclosure Report (sd)
05/25/201607:30:15Medtronic and Qualcomm Collaborate to Aim to Improve Care and...
05/19/201609:00:14Medtronic Announces U.S. Launch of Spine Essentials Demonstrating...
05/18/201609:59:00Smith & Nephew to Sell Gynecology Business to Medtronic--Update
05/18/201608:41:00Smith & Nephew Sells Gynecology Business to Medtronic; to Return...
05/18/201608:00:35Medtronic to Expand Minimally Invasive Therapy Portfolio with...
05/17/201614:00:18Medtronic EVP & MITG President Bryan Hanson to Speak at Jefferies...
05/17/201613:00:15Medtronic CEO Omar Ishrak to Speak at Goldman Sachs Global Healthcare...
05/11/201616:15:41Medtronic to Announce Financial Results for Its Fourth Quarter...
05/11/201601:02:34Medtronic and the Vikings to Unveil "The Horn" Monument on Medtronic...
05/10/201610:00:37Medtronic Announces 2016 Institutional Investor and Analyst Meeting...
05/06/201616:30:08Medtronic Unveils Data Showing Feasibility of New Approach to...
05/05/201612:00:09New Data Further Support Medtronic Leadership in Leadless Pacing...
05/04/201613:42:29Statement of Changes in Beneficial Ownership (4)
05/04/201613:40:15Statement of Changes in Beneficial Ownership (4)
05/04/201613:35:45Statement of Changes in Beneficial Ownership (4)
05/04/201613:33:58Statement of Changes in Beneficial Ownership (4)
05/04/201613:31:01Statement of Changes in Beneficial Ownership (4)
05/04/201613:27:59Statement of Changes in Beneficial Ownership (4)
05/04/201613:25:21Statement of Changes in Beneficial Ownership (4)

Medtronic and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad